Editor's Correspondence |

Is Treatment With Aspirin Combined With Dipyridamole Really More Cost-effective Than Aspirin Alone?

Judith L. Heidebrink, MD
Arch Intern Med. 2001;161(9):1236. doi:.
Text Size: A A A
Published online


I congratulate Dr Sarasin and his colleagues for their detailed cost-effectiveness analysis of antiplatelet therapy in cerebrovascular disease.1 They conclude that the combination of aspirin and dipyridamole is "more effective and less costly than aspirin alone." However, this conclusion hinges on 2 key assumptions that are flawed, particularly for medical care in the United States.

The authors estimated the daily costs for aspirin, clopidogrel, and the aspirin/dipyridamole combination at $0.02, $2.40, and $0.60, respectively. In the sensitivity analysis, the highest daily cost considered for aspirin/dipyridamole was $1.20. While this cost may be appropriate for the aspirin/dipyridamole combination available in Europe, it is a significant underestimate for the United States. In the United States, based on a 30-day pricing period, the average wholesale price for aspirin/dipyridamole is $2.95 per day, only slightly lower than that of clopidogrel ($3.21 per day) (oral communication with Boehringer Ingleheim Pharmaceuticals, Inc, Ridgefield, Conn, and Bristol-Myers Squibb Company, New York, NY; December 19, 2000). The higher US price for aspirin/dipyridamole treatment overwhelms any potential cost savings arising from its greater stroke prevention compared with aspirin alone.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Resolution